Preventive Hemlibra May Lower Hemophilia A Treatment Costs

Preventive Hemlibra May Lower Hemophilia A Treatment Costs

296566

Preventive Hemlibra May Lower Hemophilia A Treatment Costs

Starting or switching to prophylactic, or preventive Hemlibra (emicizumab) may lead to a significant reduction in treatment-associated expenses for hemophilia A patients in the U.S., a real-world study reported. These findings highlight the cost-benefits of using Hemlibra — and may help future cost analysis studies in assessing new therapies for hemophilia, the investigators said. “Importantly,” the researchers noted, their study did not factor in key secondary savings seen by children with hemophilia A taking preventive…

You must be logged in to read/download the full post.